MOZISTOBART ZORATOLIMOD
UNII 4WQE3D6M5H

Substance Identification & Data

This profile provides standardized clinical and technical data for Mozistobart Zoratolimod, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4WQE3D6M5H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2852752-99-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4WQE3D6M5H
CAS Registry Number
2852752-99-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MOZISTOBART ZORATOLIMOD
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12947
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mozistobart Zoratolimod. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MOZISTOBART ZORATOLIMOD

Common Names & Synonyms

IMMUNOGLOBULIN G1 (240-ALANINE,241-ALANINE,243-ALANINE), ANTI-(HUMAN/MACACA FASCICULARIS SIALIC ACID-BINDING IG-LIKE LECTIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL AB-125 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE (RPEGFGPP), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AB-125 .KAPPA.-CHAIN, DIMER, 455-AMIDE WITH DNA D(P-THIO)(BR5U-C-G-T-P(O)-(84-AMINO-10-OXO-3,6,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-HEXACOSAOXA-9-AZATETRAOCTACONT-1-YL)-C-G-T-G-T-S2P-C-G-T-M5RUM-M5RUM) 3'-(O-(3-HYDROXYPROPYL) HYDROGEN PHOSPHOROTHIOATE)
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD22 (SIALIC ACID BINDING IG-LIKE LECTIN 2, SIGLEC2, SIGLEC-2, B-LYMPHOCYTE CELL ADHESION MOLECULE, BL-CAM, LEU-14)), HUMANIZED MONOCLONAL ANTIBODY; CONJUGATED AT ONE GLUTAMINE RESIDUE WITH ZORATOLIMOD
MOZISTOBART ZORATOLIMOD [INN]